hindsight is a wonderful thing.....even with all the high quality medical ppls involved (including Professor Min who developed the gene-silencing for over 10 years) this is a long term play as Koos will have to re-gain confidence with the share holders.....given his past with ENTB (to be honest he should sell his part ownership of ENTB and focus on the wholly owned Regen BioPharma).
Market Data 
Markets 
AI
